Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
Cancerworld Magazine > LMICs

Posts by tag

LMICs

10 posts
Is It Biology or Geography That Decides Who Survives Childhood Cancer?
View Post
  • Delivery of Care
  • Senza categoria

Is It Biology or Geography That Decides Who Survives Childhood Cancer?

  • Shushan Hovsepyan
  • 5 June 2025

Cancer is a word no parent ever wants to hear. But when that word comes with no access to treatment, it doesn’t just hurt—it destroys hope.A year ago, I was walking through a coastal town in Africa. It was a…

View Post
ACT for Children:A Global Initiative to Tackle Inequities in Pediatric Cancer
View Post
  • Articles
  • Delivery of Care
  • Voices

ACT for Children:A Global Initiative to Tackle Inequities in Pediatric Cancer

  • Arnaud Lallouette
  • 10 May 2025

The disparity in childhood cancer outcomes is one of the world’s most pressing health inequities. While over 80% of children with cancer are cured in high-income countries (HICs), survival drops to less than 30% in low- and middle-income countries (LMICs).…

View Post
India’s HPV vaccine: another step towards eradicating cervical cancer
View Post
  • Articles
  • Delivery of Care

India’s HPV vaccine: another step towards eradicating cervical cancer

  • Rachel Brazil
  • 31 May 2024

It’s hard to remember that, at the time it was introduced in 2008, many questions were raised about whether the human papillomavirus (HPV) vaccine would be cost effective. In the intervening decade and a half, it has become abundantly clear…

View Post
Advocating for accessible cancer care in the global South: are we doing this all wrong?
View Post
  • Articles
  • Policy

Advocating for accessible cancer care in the global South: are we doing this all wrong?

  • Anna Wagstaff
  • 20 October 2023

“You have to convince the people with their hands on the levers of power. They don’t see things as we see them. They have other problems on their minds…”  Ten years after launching the Stop Cancer Now! appeal, which outlined…

View Post
Our new journal from India is enriching the cancer publications landscape
View Post
  • Voices

Our new journal from India is enriching the cancer publications landscape

  • Vanita Noronha, CRST Editor-in-Chief
  • 28 July 2023

We launched Cancer Research, Statistics and Treatment at the internationally renowned Tata Memorial Hospital, Mumbai, in 2018. It was my colleague, Professor of Medical Oncology, Kumar Prabhash, who prodded me to start the journal. I had already been the Editor-in-Chief…

View Post
AI-generated radiotherapy planning could boost access to high-quality treatment across the globe
View Post
  • Articles
  • Delivery of Care

AI-generated radiotherapy planning could boost access to high-quality treatment across the globe

  • Swagata Yadavar
  • 18 May 2023

Can artificial intelligence help design radiotherapy treatment plans, reducing time and cost while matching the quality of skilled professionals? That is the question that a new multi-centre and multi-arm ARCHERY study is trying to answer. The global study, still at…

View Post
Immunotherapy: outcomes of ultra low-dose trial offer hope for better global access
View Post
  • Articles
  • Delivery of Care

Immunotherapy: outcomes of ultra low-dose trial offer hope for better global access

  • Swagata Yadavar
  • 26 January 2023

Doctors at the Tata Memorial Hospital in Mumbai have shown that an ultra-low dose of the immunotherapy drug nivolumab significantly improves survival in patients with recurrent or newly diagnosed head and neck cancers. The findings of the single-centre phase III…

View Post
First voluntary licensing of cancer drug sets ‘vital precedent’ for the industry
View Post
  • Articles
  • Policy

First voluntary licensing of cancer drug sets ‘vital precedent’ for the industry

  • Esther Nakkazi
  • 16 November 2022

The first voluntary licence for a patented cancer medicine was signed last month on the fringes of the 2022 World Cancer Congress in Geneva. The agreement between the pharmaceutical company Novartis and the Medicines Patent Pool – a UN backed…

View Post
Begging for imatinib: why do so many patients still lack access to this lifesaver?
View Post
  • Articles
  • Policy

Begging for imatinib: why do so many patients still lack access to this lifesaver?

  • Anna Wagstaff
  • 22 July 2022

Following doctor’s orders doesn’t usually mean making a two-hour round trip to visit your hospital twice a week to beg for any spare medication on the off-chance that someone has had to change to a different drug, or was able…

View Post
North and South ‒ learning faster means learning together
View Post
  • Articles
  • Policy

North and South ‒ learning faster means learning together

  • Swagata Yadavar
  • 12 November 2021

When you look at the vast waiting area in Mumbai’s world leading Tata Memorial Cancer Hospital, pictured above, what do you see? A crowded chaotic scene where sick patients and their relatives sit around for hours, waiting, hoping for someone…

View Post
search
CancerWorld #105 Download CancerWorld #104 Download CancerWorld #103 Download CancerWorld #102 Download CancerWorld #101 Download or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • How a Brain-Destroying Protein Became Cancer’s Ally: Alpha-Synuclein Emerges as a New Target in Melanoma
    • 4 July 2025
  • CancerWorld #105 (July 2025)
    • 2 July 2025
  • How a Chicken Egg Model Could Transform Pediatric Cancer Treatment in Canada
    • 20 June 2025
  • Microbiota-Derived Bile Acids as Androgen Receptor Antagonists Enhance Anti-Tumour Immunity
    • 19 June 2025
  • Strategies Needed to Prioritise Screening in Survivors of Childhood Cancer
    • 4 June 2025
Article
  • Suheir Rasul: Protecting Human Dignity
    • 4 July 2025
  • Equity:The Word That Shaped Her Career From The Lab To The White House:The Story Of Catharine Young
    • 4 July 2025
  • Curious, Rejected,Accepted: An ESO Fellow’s Road to Becoming an Oncologist
    • 3 July 2025
Social

Would you follow us ?

Contents
  • Suheir Rasul: Protecting Human Dignity
    • 4 July 2025
  • Equity:The Word That Shaped Her Career From The Lab To The White House:The Story Of Catharine Young
    • 4 July 2025
  • Curious, Rejected,Accepted: An ESO Fellow’s Road to Becoming an Oncologist
    • 3 July 2025
MENU
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
Cancerworld Magazine
  • About us
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is published by OncoDaily (P53 Inc.) | Mailing Address: 867 Boylston st, 5th floor, Ste 1094 Boston, MA 02116, United States | [email protected]

Archivio Cancerworld

Input your search keywords and press Enter.